Details for New Drug Application (NDA): 018977
✉ Email this page to a colleague
The generic ingredient in TRI-NORINYL 28-DAY is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 018977
Tradename: | TRI-NORINYL 28-DAY |
Applicant: | Dr Reddys Labs Sa |
Ingredient: | ethinyl estradiol; norethindrone |
Patents: | 0 |
Suppliers and Packaging for NDA: 018977
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRI-NORINYL 21-DAY | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018977 | NDA AUTHORIZED GENERIC | Mayne Pharma Inc. | 51862-471 | 51862-471-06 | 6 BLISTER PACK in 1 CARTON (51862-471-06) / 1 KIT in 1 BLISTER PACK (51862-471-01) |
TRI-NORINYL 28-DAY | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 018977 | NDA AUTHORIZED GENERIC | Mayne Pharma Inc. | 51862-471 | 51862-471-06 | 6 BLISTER PACK in 1 CARTON (51862-471-06) / 1 KIT in 1 BLISTER PACK (51862-471-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-21 | Strength | 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG | ||||
Approval Date: | Apr 13, 1984 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG | ||||
Approval Date: | Apr 13, 1984 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 018977
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Dr Reddys Labs Sa | TRI-NORINYL 21-DAY | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018977-001 | Apr 13, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Dr Reddys Labs Sa | TRI-NORINYL 28-DAY | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 018977-002 | Apr 13, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription